임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
55건 표시
- 2상모집 중단 (진행 중)· Post-COVID ConditionStudy to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID
협력: 화이자
- 2상모집 중단 (진행 중)· Prostate CancerComeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)
협력: 화이자
- 2상모집 중단 (진행 중)· Pneumococcal DiseaseA Study to Learn About How a New Pneumococcal Vaccine Works in Infants
리드: 화이자
- 2상모집 중단 (진행 중)· Breast NeoplasmsA Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
리드: 화이자
- 2상모집 중단 (진행 중)· Metastatic Colorectal CancerStudy of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
협력: 화이자
- 2상모집 중단 (진행 중)· Advanced or Metastatic Breast CancerA Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
리드: 화이자
- 2상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
리드: 화이자
- 2상모집 중단 (진행 중)· Sickle Cell DiseaseAssessing Physical Function in Sickle Cell Patients Taking Voxelotor
협력: 화이자
- 2상모집 중단 (진행 중)· Diabetes Mellitus, Type 1Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)
협력: 화이자
- 2상모집 중단 (진행 중)· Metastatic Breast CancerA Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain
협력: 화이자
- 2상모집 중단 (진행 중)· Metastatic Breast CancerFulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression
협력: 화이자, 로슈
- 2상모집 중단 (진행 중)· Metastatic Colorectal CancerA Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
리드: 화이자 · 협력: 일라이 릴리, 머크(MSD)
- 2상모집 중단 (진행 중)· Breast CancerStudy for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies
리드: 화이자
- 2상모집 중단 (진행 중)· Tuberculosis, Multidrug-ResistantEfficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
협력: 노바티스, 화이자
- 2상모집 중단 (진행 중)· Advanced or Metastatic ROS1-Positive Non-Small Cell Lung CancerA Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer
협력: 화이자
- 2상모집 중단 (진행 중)· Urothelial Carcinoma BladderNeoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer
협력: 화이자
- 2상모집 중단 (진행 중)· Metastatic Uveal MelanomaBinimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
협력: 화이자
- 2상모집 중단 (진행 중)· Uterine NeoplasmsBasket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
리드: 화이자
- 2상모집 중단 (진행 중)· LiposarcomaStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
리드: 화이자
- 2상모집 중단 (진행 중)· Small Cell Lung CancerPF-07104091 as a Single Agent and in Combination Therapy
리드: 화이자
- 2상모집 중단 (진행 중)· Colorectal CarcinomaTucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
리드: 화이자
- 2상모집 중단 (진행 중)· Acute Myelogenous Leukemia (AML) Due to TherapyCPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia
협력: 화이자
- 2상모집 중단 (진행 중)· Acute Myeloid LeukemiaFractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
협력: 화이자
- 2상모집 중단 (진행 중)· Stage III Breast CancerAvelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
협력: 길리어드, 화이자
- 2상모집 중단 (진행 중)· Breast Cancer Stage IIAdjuvant Palbociclib in Elderly Patients With Breast Cancer
협력: 화이자
- 2상모집 중단 (진행 중)· Ewing SarcomaStudy Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
리드: 화이자
- 2상모집 중단 (진행 중)· Prostate CancerA Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
협력: 화이자
- 2상모집 중단 (진행 중)· PheochromocytomaStudy of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
협력: 화이자
- 2상모집 중단 (진행 중)· Breast CancerNeoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer
협력: 화이자
- 2상모집 중단 (진행 중)· Recurrent Extensive Stage Small Cell Lung CarcinomaTalazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
협력: 화이자
- 2상모집 중단 (진행 중)· Colorectal NeoplasmsEfficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
리드: 화이자 · 협력: 머크(MSD)
- 2상모집 중단 (진행 중)· Breast CancerThe AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
협력: 화이자
- 2상모집 중단 (진행 중)· Head and Neck Squamous Cell CarcinomaLos Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
협력: 화이자
- 2상모집 중단 (진행 중)· Prostate CancerPalbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
협력: 화이자
- 2상모집 중단 (진행 중)· Hemophilia BLong-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B
리드: 화이자
- 2상모집 중단 (진행 중)· Female Breast CarcinomaTrial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer
협력: 화이자
- 2상모집 중단 (진행 중)· Metastatic Breast CancerPalbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
협력: 화이자
- 2상모집 중단 (진행 중)· Breast CancerPalbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
협력: 화이자
- 2상모집 중단 (진행 중)· Breast CancerPErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
협력: 아스트라제네카, 화이자
- 2상모집 중단 (진행 중)· Ciliary Body and Choroid Melanoma, Medium/Large SizeSunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma
협력: 화이자
- 2상모집 중단 (진행 중)· Breast NeoplasmsPD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
협력: 화이자
- 2상모집 중단 (진행 중)· Advanced Rare TumoursA Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
협력: 화이자
- 2상모집 중단 (진행 중)· Prostate CancerSunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy
협력: 화이자
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.